Table 4 Univariate analysis for CMR predictors of Major Adverse Cardiac Events

CMR Pattern

P = 0.094

2.16 (0.86–5.38)

  Nodular

13

137

  Linear

9

44

Wall distribution

P = 0.103

  Subepicardial

15

153

  Midwall

7

26

  Transmural

0

2

Localization

P = 0.65

  Posterolateral

13

109

  Septal

1

2

  Anterior

2

15

  Septal + posterolateral

6

54

Presence of pericardial effusion

9

49

P = 0.18

1.86 (0.75–4.64)

Gender

P = 0.87

  Male

137

17

  Female

44

5

Presence and extent of Early Gadolinium Enhancement (% myocardial surface area)

2.2 % ± 4.1

5.1 % ± 6.0

P = 0.005

Number of segments with EGE

1.0 ± 1.7

1.9 ± 1.9

P = 0.04

Age

47 ± 13

42 ± 17

P = 0.14

0.91 (0.32–2.62)

Presence of asynergic segments on CMR

6

33

P = 0.31

1.68 (0.61–4.62)

Presence of EGE in 2 opposed walls

3

27

P = 0.87

0.90 (0.25–3.25)

Presence of LGE in 2 opposed walls

8

69

P = 0.87

0.93 (0.37–2.32)

Myocardial extent of Late Gadolinium Enhancement (% myocardial surface area)

11.9 % ± 6.8

11.3 % ± 7.2

P = 0.72

Number of segments with LGE

4.2 ± 2.4

3.7 ± 2.2

P = 0.41

Presence of T2-hypersignal

8

92

P = 0.69

0.81 (0.27–2.46)

Presence of T2-hypersignal in opposed walls

2

32

P = 0.50

0.59 (0.13–2.79)

Myocardial extent of hyper T2 signal (% myocardial surface area)

4.9 ± 4.9

7.0 ± 7.0

P = 0.16

Number of segments with hyper T2 signal

1.9 ± 1.8

1.9 ± 1.9

P = 0.9

Initial end-diastolic LV volume, ml/m²

77 ± 22

73 ± 18

P = 0.39

Initial LV ejection fraction, %

51.9 ± 9

57.6 ± 8.9

P = 0.009